STOCK TITAN

Omada Health (NASDAQ: OMDA) CAO sells 1,041 shares after option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Omada Health, Inc.'s Chief Accounting Officer, Gracey Craig, exercised stock options to acquire 1,041 shares of common stock at $6.57 per share and, on the same date, sold 1,041 shares in an open-market transaction at $24.00 per share pursuant to a 10b5-1 trading plan. Following these transactions, she holds 15,441 common shares directly and 33,334 stock options that remain outstanding.

Positive

  • None.

Negative

  • None.
Insider Gracey Craig
Role Chief Accounting Officer
Sold 1,041 shs ($25K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 1,041 $0.00 --
Exercise Common Stock 1,041 $6.57 $7K
Sale Common Stock 1,041 $24.00 $25K
Holdings After Transaction: Stock Option (Right to Buy) — 33,334 shares (Direct); Common Stock — 16,482 shares (Direct)
Footnotes (1)
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. 25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Shares sold 1,041 shares Common stock sold in open market on July 13, 2026
Sale price $24.00 per share Price for 1,041 common shares sold on July 13, 2026
Options exercised 1,041 shares Shares acquired via stock option exercise on July 13, 2026
Exercise price $6.57 per share Exercise or conversion price of Stock Option (Right to Buy)
Shares held after sale 15,441 shares Direct common stock holdings after reported transactions
Options remaining 33,334 options Stock Option (Right to Buy) balance after exercising 1,041 options
Option expiration October 23, 2034 Expiration date of the Stock Option (Right to Buy)
Vesting Commencement Date September 9, 2024 Date from which option vesting schedule is measured
10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"
A 10b5-1 trading plan is a pre-arranged strategy that allows company insiders to buy or sell company stock at set times, regardless of their current knowledge about the company's situation. It acts like a scheduled appointment for trading, helping prevent the appearance of impropriety or insider trading. This plan provides a way for insiders to sell or buy shares in a controlled, transparent manner, offering reassurance to investors about fair trading practices.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) with underlying Common Stock"
Vesting Commencement Date financial
"measured from September 9, 2024 (the "Vesting Commencement Date")"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider trading activity did Omada Health (OMDA) officer Gracey Craig report?

Gracey Craig reported exercising options for 1,041 shares of Omada Health common stock at $6.57 per share and selling 1,041 shares in an open-market transaction at $24.00 per share, all on July 13, 2026.

How many Omada Health (OMDA) shares did Gracey Craig sell and at what price?

Gracey Craig sold 1,041 Omada Health common shares at an average price of $24.00 per share. The sale was reported as an open-market transaction, with the shares held directly before the trade.

What stock options did Gracey Craig exercise in Omada Health (OMDA)?

She exercised a Stock Option (Right to Buy) for 1,041 underlying Omada Health shares at an exercise price of $6.57 per share. After the exercise, 33,334 stock options remained outstanding, expiring on October 23, 2034.

How many Omada Health (OMDA) shares and options does Gracey Craig hold after the transactions?

Following the reported transactions, Gracey Craig directly holds 15,441 Omada Health common shares and 33,334 stock options. These figures reflect her position after the option exercise and same-day open-market sale of 1,041 shares.

Was the Omada Health (OMDA) insider sale made under a 10b5-1 trading plan?

Yes. A footnote states the sale was made pursuant to a 10b5-1 trading plan adopted by Gracey Craig. Such pre-arranged plans automate trading, reducing the significance of the exact timing of the transaction for signaling purposes.

What is the vesting schedule of Gracey Craig’s Omada Health (OMDA) stock option?

The option vests 25% on the first anniversary of the September 9, 2024 Vesting Commencement Date, with 1/48th of the total shares vesting monthly thereafter, so that 100% of the option is fully vested on the fourth anniversary.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gracey Craig

(Last)(First)(Middle)
C/O OMADA HEALTH, INC.
611 GATEWAY BLVD, SUITE 120

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/13/2026M1,041A$6.5716,482D
Common Stock07/13/2026S(1)1,041D$2415,441D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$6.5707/13/2026M1,041 (2)10/23/2034Common Stock1,041$033,334D
Explanation of Responses:
1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
2. 25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
/s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey07/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)